Featured Research

from universities, journals, and other organizations

What Immune Cells See: Ins And Outs Of Peptide Processing

Date:
November 21, 2007
Source:
Journal of Clinical Investigation
Summary:
Immune cells known as T cells help us clear invading microbes, such as HIV, from our bodies, but they can also cause autoimmunity when they inappropriately attack our own tissues. T cells are activated when a receptor on their surface (the TCR) recognizes a specific complex of a peptide fragment bound to a protein known as an MHC molecule.

Immune cells known as T cells help us clear invading microbes, such as HIV, from our bodies, but they can also cause autoimmunity when they inappropriately attack our own tissues. T cells are activated when a receptor on their surface (the TCR) recognizes a specific complex of a peptide fragment bound to a protein known as an MHC molecule.

Defining the peptides identified by T cells mediating autoimmunity and immune responses against invading microbes, as well as harnessing this information for the design of therapeutics and vaccines, is an area of intensive investigation.

New insight into these matters is provided in the November issue of the Journal of Clinical Investigation by two studies that report technical advances in the field. The clinical implications of these are discussed in an accompanying commentary by Luc Teyton from The Scripps Research Institute, La Jolla.

Wahlstrom and colleagues from the Karolinska University Hospital, Sweden, developed a strategy to determine the peptide fragments bound by human MHC molecules activating inappropriate immune responses in vivo. Using this approach they identified 78 peptide fragments bound to the MHC molecule HLA-DR on cells isolated from the lungs of patients with sarcoidosis, an inflammatory disease of the lungs mediated largely by CD4+ T cells.

The authors suggest that this approach might be used to identify the peptides recognized by autoreactive T cells that attack the body to cause diseases such as diabetes and rheumatoid arthritis, information that could lead to the development of new treatment strategies.

By contrast, Le Gall and colleagues from Massachusetts General Hospital and Harvard Medical School, Boston, have provided insight into the peptides recognized by CD8+ T cells fighting infection with HIV. The main peptide fragment of the HIV-1 protein Gag that binds the human MHC molecule HLA-A3 is known as the immunodominant epitope.

In vitro assays determined that the amino acid sequence flanking the immunodominant epitope caused the immunodominance as moving these sequences to flank other peptides increased the frequency with which they bound HLA-A3. The authors therefore suggested that these flanking sequences might be used to enhance the effectiveness of HIV vaccines.

First journal article: Identification of HLA-DR -- bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis

Second journal article: Portable flanking sequences modulate CTL epitope processing


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "What Immune Cells See: Ins And Outs Of Peptide Processing." ScienceDaily. ScienceDaily, 21 November 2007. <www.sciencedaily.com/releases/2007/11/071101193354.htm>.
Journal of Clinical Investigation. (2007, November 21). What Immune Cells See: Ins And Outs Of Peptide Processing. ScienceDaily. Retrieved September 23, 2014 from www.sciencedaily.com/releases/2007/11/071101193354.htm
Journal of Clinical Investigation. "What Immune Cells See: Ins And Outs Of Peptide Processing." ScienceDaily. www.sciencedaily.com/releases/2007/11/071101193354.htm (accessed September 23, 2014).

Share This



More Health & Medicine News

Tuesday, September 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Ebola Doctor Says Border Controls Critical

Ebola Doctor Says Border Controls Critical

AP (Sep. 22, 2014) A Florida doctor who helped fight the expanding Ebola outbreak in West Africa says the disease can be stopped, but only if nations quickly step up their response and make border control a priority. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Global Ebola Aid Increasing But Critics Say It's Late

Global Ebola Aid Increasing But Critics Say It's Late

Newsy (Sep. 21, 2014) More than 100 tons of medical supplies were sent to West Africa on Saturday, but aid workers say the global response is still sluggish. Video provided by Newsy
Powered by NewsLook.com
Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins